Drug Groups Warn US Pricing Policy Hinders New Medicines
Drug advocacy groups in Sweden are warning that the US pricing policy is hindering the launch of new medicines. The lack of clarity on Swedish pricing and reimbursement has put new medicine launches on hold. They argue that the policy impacts innovation and future drug availability.
Topics
Developing
- 907d Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.
- 907d Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
- 907d Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est.
- 907d Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.
Sources · 7 independent
Mastodon
“Drug groups warn US pricing policy is choking off new medicines in Sweden”
Unlock the full story
Get a Pro subscription or above to see the live story progression and the full list of independent sources confirming each event as they happen.
Log in to upgrade